ATOSSA THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
ATOSSA THERAPEUTICS, INC. (ATOS) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $1.00 thousand as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2022-02-28
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.00K.
- 2021-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $242.00.
- 2021-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $681.00.
- 2020-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.40K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount as first filed |
|---|---|---|
| 2021-12-31 | $1.00K 10-K · filed 2022-02-28 | |
| 2021-06-30 | $242.00 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $681.00 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $1.40K 10-K · filed 2021-03-31 | |
| 2020-09-30 | $2.30K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $15.40K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $4.50K 10-Q · filed 2021-05-14 | |
| 2019-12-31 | $6.10K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $13.00K 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $11.50K 10-Q · filed 2020-08-13 | |
| 2019-03-31 | $12.90K 10-Q · filed 2020-05-13 | $12.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |